BillionToOne is a precision diagnostics company that makes molecular diagnostics. Healthcare Medical Biotech

About BillionToOne

BillionToOne is tracked on 100Xfounder as a healthcare company, founded in 2016, based in San Francisco Bay Area, California, USA, currently mapped to the Series C stage. BillionToOne is a precision diagnostics company that makes molecular diagnostics. Healthcare Medical Biotech

Profile snapshot: Founders linked: BillionToOne Team. Funding tracked: $125.00M. Hiring focus: Open Roles. Tech tags: Python, GCP, BigQuery, and React.

Recent signals:

  • BillionToOne appears in the 100Xfounder startup directory import feed.

Why it Matters

BillionToOne is worth tracking because its funding history is already mapped here, including a $125.00M round, the hiring signal points to active work across Open Roles roles, recent coverage is already tied back to this page, and BillionToOne Team's founder profile is linked directly from the company page. Use this page as the starting point before moving into the company news hub, founder profiles, and related market pages.

Funding Snapshot

Total Funding: $125.00MLast Round: Series C Y Combinator, $125M Series C in 2022All Rounds: 1
  • Series C | Y Combinator, $125M Series C in 2022

Hiring Roles

This company is actively hiring.

Open Roles

Meet the Founders

Tech Stack

PythonGCPBigQueryReact

Last updated: May 12, 2026

BillionToOne research snapshot

This page is assembled from the published company profile, linked founder directory records, and tagged newsroom context already stored on 100Xfounder. It is most useful as a quick starting point before moving into the deeper company, founder, and hub routes below.

  • Company summary

    BillionToOne is a precision diagnostics company that makes molecular diagnostics. Healthcare Medical Biotech

  • Founders covered

    BillionToOne Team

  • Market position

    Healthcare | Series C | San Francisco Bay Area, California, USA

  • Newsroom signal

    No direct company-tagged stories are mapped yet; use the connected hubs below for broader market context.

  • Funding signal

    $125.00M

Best next clicks

Start with the lead founder profile if you want operator context first, then return to the company news hub for chronology.

Related Companies

Alternatives in Healthcare with comparable market signals.

Discover Now

Newsroom and topic pages connected to BillionToOne.

No company-specific newsroom stories available yet.

Contextual Research Links

Jump to country, industry, stage, startup taxonomy, and newsroom routes tied to this company.

Want to get featured on 100Xfounder?

Want your company featured with founder details and funding visibility? Start here.

FAQs About BillionToOne

Common questions people ask about this profile.

What is BillionToOne?

BillionToOne is a precision diagnostics company that makes molecular diagnostics. Healthcare Medical Biotech

Who founded BillionToOne?

BillionToOne is associated with BillionToOne Team on 100Xfounder.

Where is BillionToOne located?

BillionToOne is listed in San Francisco Bay Area, California, USA.

What stage is BillionToOne in?

BillionToOne is currently mapped to Series C. Funding context: Y Combinator, $125M Series C in 2022

What is the latest funding round of BillionToOne?

BillionToOne's latest tracked round is Series C Y Combinator, $125M Series C in 2022. Total tracked rounds: 1.

Is BillionToOne hiring now?

BillionToOne hiring status: Open Roles.

What technologies does BillionToOne use?

BillionToOne is associated with Python, GCP, BigQuery, and React.

Is BillionToOne verified on 100Xfounder?

Yes. BillionToOne is currently marked verified on 100Xfounder as of May 12, 2026.

How can users connect with BillionToOne founders?

Users can move from the company page to any linked founder profiles, review the company news hub, and use listed company links when public contact routes are available.